Highest concentration of breast-milk-derived exosomes in colostrum

Pediatr Int. 2022 Jan;64(1):e15346. doi: 10.1111/ped.15346.

Abstract

Background: Exosomes are nanosized extracellular vesicles, that play important roles in intercellular immune regulation. They have potential therapeutic utility for neonatal diseases including necrotizing enterocolitis. Breast-milk-derived exosomes have recently shown beneficial effects on intestinal damage in vitro and in vivo. However, the chronological change in breast-milk-derived exosome concentrations after delivery are unclear.

Methods: In this prospective study, we enrolled 17 mothers who delivered premature infants admitted to a neonatal intensive care unit in Japan. We measured the consecutive concentrations of breast-milk-derived exosomes in the mothers for 48 weeks after delivery.

Results: The median concentration of breast-milk-derived exosomes was 1.62 × 108 particles/ml in colostrum, showing a significant decrease after 2 weeks (P < 0.01). There was no association between the exosome concentration in colostrum and maternal perinatal factors including parity, mode of delivery, maternal age, and gestational age at delivery.

Conclusions: We concluded that breast-milk-derived exosomes were the richest in colostrum. Our basic data regarding breast-milk-derived exosomes are expected to aid in the clinical application of exosomes for treating neonatal diseases.

Keywords: breast milk; colostrum; exosome; neonate; preterm.

MeSH terms

  • Colostrum
  • Enterocolitis, Necrotizing*
  • Exosomes*
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Milk, Human
  • Pregnancy
  • Prospective Studies